Trial Outcomes & Findings for Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup (NCT NCT03705273)

NCT ID: NCT03705273

Last Updated: 2021-11-08

Results Overview

Presence of nausea after medication administration (yes/no) measured by participant self-report

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

40 participants

Primary outcome timeframe

1 hour

Results posted on

2021-11-08

Participant Flow

Forty participants were enrolled and randomized, of which 20 were randomized to receive dexamethasone tablets.

Participant milestones

Participant milestones
Measure
Dexamethasone Tablets
Dexamethasone tablets crushed and administered in apple sauce or pudding at a dose of 0.6 mg/kg
Dexamethasone-IV Solution-in-syrup
Dexamethasone-IV solution-in-syrup at a dose of 0.6 mg/kg
Overall Study
STARTED
20
20
Overall Study
COMPLETED
20
20
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dexamethasone IV for PO
n=20 Participants
Dexamethasone IV for PO solution mixed with sugar syrup to be given orally Dexamethasone IV for PO: Common pediatric emergency department practice
Dexamethasone Crushed Tablets
n=20 Participants
Dexamethasone tablet crushed and placed in apple sauce or pudding to be given orally or dexamethasone IV solution in cherry syrup
Total
n=40 Participants
Total of all reporting groups
Diagnosis asthma
15 Participants
n=5 Participants
16 Participants
n=7 Participants
31 Participants
n=5 Participants
Diagnosis croup
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Age, Continuous
2.75 years
STANDARD_DEVIATION 1.88 • n=5 Participants
2.70 years
STANDARD_DEVIATION 1.92 • n=7 Participants
2.75 years
STANDARD_DEVIATION 1.88 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
12 Participants
n=7 Participants
19 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
8 Participants
n=7 Participants
21 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
15 Participants
n=5 Participants
15 Participants
n=7 Participants
30 Participants
n=5 Participants
Race (NIH/OMB)
White
5 Participants
n=5 Participants
5 Participants
n=7 Participants
10 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
20 participants
n=5 Participants
20 participants
n=7 Participants
40 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 hour

Presence of nausea after medication administration (yes/no) measured by participant self-report

Outcome measures

Outcome measures
Measure
Dexamethasone Tablets
n=20 Participants
Dexamethasone tablets crushed and mixed in apple sauce
Dexamethasone IV for PO
n=20 Participants
Dexamethasone IV solution mixed with cherry syrup
Number of Participants With Nausea
3 Participants
0 Participants

SECONDARY outcome

Timeframe: 1 hour

Reason for patient needing a second dose of dexamethasone; such as spit dose up or vomiting dose

Outcome measures

Outcome measures
Measure
Dexamethasone Tablets
n=20 Participants
Dexamethasone tablets crushed and mixed in apple sauce
Dexamethasone IV for PO
n=20 Participants
Dexamethasone IV solution mixed with cherry syrup
Number of Participants Requiring Second Dose of Dexamethasone
0 Participants
0 Participants

Adverse Events

Dexamethasone IV for PO

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Dexamethasone Crushed Tablets

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Donald H. Arnold, MD, MPH

Vanderbilt University School of Medicine

Phone: 16155790516

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place